The data is held in a public repository, GitHub repository: <https://github.com/mbchxaa6/Pseudo-colouring_ECGs_LQTS_QT-nomogram> Ref: <https://doi.org/10.5281/zenodo.3940377>.

Introduction {#sec001}
============

Background and significance {#sec002}
---------------------------

An electrocardiogram (ECG or EKG) is a graphical representation of the electrical activity of the heart, widely used as a clinical tool for monitoring heart function and detecting cardiac pathologies \[[@pone.0237854.ref001]\]. An important measurement on the ECG is the QT-interval, which represents the duration of the ventricular depolarization and repolarization cycle. It is measured from the beginning of the QRS complex (illustrating ventricular depolarization) to the end of the T-wave (showing subsequent repolarization) \[[@pone.0237854.ref001], [@pone.0237854.ref002]\], as shown in [Fig 1](#pone.0237854.g001){ref-type="fig"}.

![An illustration of electrocardiogram (ECG or EKG) waveforms and the QT-interval.\
Different 'waves' (peaks and troughs) are labelled with letters and represent different stages of a heartbeat. The QT-interval is measured from the beginning of the Q-wave to the end of the T-wave, identified here using the tangent method drawn at the maximum down-slope of the T-wave.](pone.0237854.g001){#pone.0237854.g001}

The QT-interval is of considerable clinical importance, primarily because its prolongation can increase the risk of a life-threatening arrhythmia known as *Torsades de Pointes* (TdP), a form of polymorphic ventricular tachycardia that is the leading cause of sudden cardiac death in young, otherwise healthy people \[[@pone.0237854.ref003]--[@pone.0237854.ref006]\]. Prolongation of the QT-interval indicates a cardiac disorder known as 'long QT syndrome'(LQTS), which is caused by the malfunction of cardiac ion channels impairing ventricular repolarization; it manifests as a longer QT-interval than normal on the ECG \[[@pone.0237854.ref007], [@pone.0237854.ref008]\]. The TdP arrhythmia is often precipitated by triggers such as physical activity (notably swimming) \[[@pone.0237854.ref009]\], and stress-related emotion \[[@pone.0237854.ref010]\]. Athletes with LQTS are thus particularly at risk of TdP episodes \[[@pone.0237854.ref009], [@pone.0237854.ref011], [@pone.0237854.ref012]\]. A major difficulty with identifying LQTS is that it is often asymptomatic; sudden cardiac death can be the first clinical manifestation, and therefore it may go undiagnosed, or underdiagnosed, without ECG assessment \[[@pone.0237854.ref013]--[@pone.0237854.ref015]\].

LQTS can be congenital---a result of genetic mutations in cardiac channelopathies, as seen in Romano--Ward syndrome \[[@pone.0237854.ref016]\]---or acquired, resulting from the clinical administration of certain drugs \[[@pone.0237854.ref003], [@pone.0237854.ref017]\]. There are many commonly prescribed medications that can prolong the QT-interval, including antihistamines, antibiotics, antidepressants and antiarrhythmic drugs \[[@pone.0237854.ref003], [@pone.0237854.ref017]\]. Drug interactions that block the human ether-a-go-go-related gene (hERG) potassium channel are the most common cause of drug-induced long QT syndrome (diLQTS) \[[@pone.0237854.ref018], [@pone.0237854.ref019]\]. These drugs are associated with large and increasing numbers of sudden deaths, and preventive strategies could therefore save many lives \[[@pone.0237854.ref003], [@pone.0237854.ref020], [@pone.0237854.ref021]\].

Frequent ECG monitoring is strongly recommended for people at risk of acquiring diLQTS, including patients on a known QT-prolonging drug and patients participating in a clinical trial testing a new drug \[[@pone.0237854.ref022], [@pone.0237854.ref023]\]. A baseline ECG, before taking a QT-prolonging drug, and follow-up ECGs to monitor the QT-interval are advisable \[[@pone.0237854.ref024], [@pone.0237854.ref025]\]. Recent innovations in home healthcare technologies have made it possible to record high-quality, clinically reliable ECG data outside of the clinical environment \[[@pone.0237854.ref026]--[@pone.0237854.ref029]\], but interpreting such data correctly in a timely manner still remains a major challenge \[[@pone.0237854.ref030], [@pone.0237854.ref031]\]. One approach involves monitoring patients' ECGs remotely, where the ECG report is referred to a clinician who specialises in ECG interpretation \[[@pone.0237854.ref026]--[@pone.0237854.ref029]\]. However, a single dose of a QT-prolonging drug could dramatically prolong the QT-interval within 24 hours for some patients, with the risk of TdP increasing with continued use \[[@pone.0237854.ref032]\]. At present, remote expert monitoring is too infrequent and costly to be an effective way of managing this issue for everyone at risk of acquiring diLQTS.

While there are computerised methods for interpreting the ECG, the accuracy of these methods remains limited \[[@pone.0237854.ref030], [@pone.0237854.ref031]\]. Challenges of automating ECG interpretation include the correct recognition of the ECG waveforms, in particular the amplitude and duration characteristics (which differ substantially across individuals), and the precise determination of the onset and offset of the different waves and complexes (P-wave, QRS complex, T-wave) \[[@pone.0237854.ref030]\].

Automated QT measurement algorithms have proved unsatisfactory for detecting LQTS in particular \[[@pone.0237854.ref033]--[@pone.0237854.ref039]\]. Garg and Lehmann \[[@pone.0237854.ref033]\] found that even a widely used computerized ECG analysis system was not able to detect QT-interval prolongation in 52.5% of patients affected. Research has also shown that drug-induced QT-prolongation can be underestimated and under-reported by computerised methods in patients on Methadone, a drug that is infamous for prolonging the QT-interval and increasing the risk of TdP \[[@pone.0237854.ref038]\]. A major challenge for automated QT algorithms is identifying the precise end of the T-wave (the terminal point), especially when the T-wave's morphology is abnormal \[[@pone.0237854.ref002], [@pone.0237854.ref040], [@pone.0237854.ref041]\]. This is particularly problematic, as QT-prolonging drugs also often affect the morphology of the T-wave; for example, patients on pure hERG-blocking drugs can develop flat, asymmetric, and notched T waves, whilst patients on multi-channel blocking drugs (e.g. hERG-blocking with lesser calcium and late sodium block) can develop more distorted, bizarre, T-waves \[[@pone.0237854.ref042]\]. In fact, specific T-wave patterns can aid detection of LQTS \[[@pone.0237854.ref043]\], and large T-U waves are known to precede TdP \[[@pone.0237854.ref044]\]. These indicators are lost by automated QT algorithms, however, as they work by abstracting the ECG data into a number (the calculated length of the QT-interval). As such, the human visual validation of QT-prolongation on the ECG remains mandatory in clinical practice, and provides the richest information for recognizing LQTS \[[@pone.0237854.ref030], [@pone.0237854.ref033]--[@pone.0237854.ref039]\].

Giving laypeople the means to detect when the QT-interval is prolonged without having to rely on an external interpreter could lead to a step-change in the detection and management of diLQTS, as well as helping to reduce the development of life-threatening complications in situations that place individuals at risk of QT-interval prolongation. ECG interpretation is complex, however, and detecting QT-prolongation on the ECG is particularly difficult, even for clinicians \[[@pone.0237854.ref045], [@pone.0237854.ref046]\]. From a perceptual-cognitive perspective, this may be related to the fact that people are poor at perceiving quantity represented along a horizontal scale \[[@pone.0237854.ref047]--[@pone.0237854.ref049]\]. Research has also shown that changes in the T-wave morphology and/or artifacts in the ECG signal can cause misinterpretation of the QT-interval length \[[@pone.0237854.ref040], [@pone.0237854.ref041], [@pone.0237854.ref050], [@pone.0237854.ref051]\]. The effect of heart rate on the QT-interval is another challenge, as it is the proportionate rather than absolute length that is important, and it is common to misinterpret the QT-interval at heart rates that differ from the 'standard' 60 bpm \[[@pone.0237854.ref052]\].

Visualisation techniques have the potential to highlight abnormal changes within the ECG, by supporting intuitive visual perception of the issues. Pre-attentive processing theory, which outlines a set of visual properties known to be detected rapidly and accurately by the human eye, is considered to be especially powerful for designing effective visualisations \[[@pone.0237854.ref053]--[@pone.0237854.ref055]\]. Colour is one of the most effective pre-attentive attributes that is noticed without conscious effort \[[@pone.0237854.ref056], [@pone.0237854.ref057]\]. A useful technique is pseudo-colouring, which encodes continuously varying values using a sequence of colours \[[@pone.0237854.ref055]\]. It has been widely used to support diagnosis from medical images, including breast disease \[[@pone.0237854.ref058]\], and for highlighting details in organs and bones structures that would otherwise be difficult to perceive \[[@pone.0237854.ref059], [@pone.0237854.ref061]\]. It is also used extensively in geographic and time series visualisations, where applications include encoding elevation in the data or showing changes over time \[[@pone.0237854.ref055], [@pone.0237854.ref060]\]. To our knowledge, no prior work has used pseudo-colouring to support ECG interpretation.

In this paper, we investigate whether a pseudo-colouring technique can reliably show prolongation of the QT-interval on an ECG, such that it be identified by a lay person. In an earlier feasibility study, we found that superimposing pseudo-colouring on the ECG using a spectrum-approximation colour sequence significantly improved people's ability to detect increases in the QT-interval at a low normal heart rate, when compared with a reference ECG stimulus showing a normal QT baseline \[[@pone.0237854.ref051]\]. This initial investigation had several limitations that affected the generalisability of the results. Firstly, the ECGs all had a single, regular heart rate of 60 bpm, and it is unknown how the technique would perform at higher or lower heart rates. The ECGs belonged to the same patient, who was taking the QT-prolonging drug ('Dofetilide', an antiarrhythmic drug with a pure hERG blocker) and subsequently experienced a gradual increase in the QT-interval from the normal QT baseline. It is well-known that the ECG differs from one individual to another, and that different types of drug can affect the ECG in different ways. The study examined only sensitivity (identifying true positives); for self-monitoring, it is important also to examine specificity (identifying true negatives). Finally, and most importantly, the study design allowed people to compare the ECG with a normal baseline. Such a baseline would be hard to produce in self-monitoring situations, not least because it would have to be adjusted according to heart rate. Therefore, this study tests the technique by presenting the ECGs one by one, asking participants to judge whether QT-prolongation has occurred when viewing just a single image, rather than comparing it with a baseline.

Objective {#sec003}
---------

The objective of the study was to evaluate the effectiveness of the pseudo-colouring technique in displaying QT-prolongation risk threshold on the ECG, when the data is displayed on two coordinate systems: Cartesian and Polar. Accuracy was quantified in terms of both sensitivity and specificity. The technique was tested with QT-intervals across several heart rates for multiple patients on different QT-prolonging drugs. No comparison baseline ECG was provided.

Materials and methods {#sec004}
=====================

In this section, we provide a detailed description of how the ECGs images were produced and displayed, and the experiment designed to evaluate the effectiveness of the technique. The ECGs shown in the figures are reduced in size for inclusion in the paper. All of the full size ECG images used in the experiment, along with the R scripts used to create them, can be found in \[[@pone.0237854.ref062]\].

ECG data acquisition {#sec005}
--------------------

The ECG datasets were acquired from a clinical trial study that was conducted to assess the effects of different types of known QT-prolonging drugs, including a pure hERG potassium channel blocker and multichannel blockers, on the ECG of healthy subjects \[[@pone.0237854.ref063]\]. The open ECG datasets are available online from the PhysioNet database \[[@pone.0237854.ref064]\].

Visualisation design {#sec006}
--------------------

The visualisation was created in two layers. The first layer plotted the ECG using the standard method, which is a two dimensional line graph displaying the amplitude, or voltage, of the electrical signal along the Y-axis and the time in milliseconds (ms) along the X-axis. We used the ECG data from lead II, as the QT-interval is conventionally measured in this lead \[[@pone.0237854.ref002], [@pone.0237854.ref017]\]. The pseudo-colouring was then applied in a second layer, following a series of steps: identifying individual heartbeats via R-peak detection; applying pseudo-colouring to each heartbeat; adjusting the colouring according according to heart rate; displaying the data on either a Cartesian (current standard) or Polar coordinate system.

### Identifying individual heartbeats {#sec007}

The R-wave peaks (points with greatest amplitude) were detected in the raw ECG datasets using an automated numerical math function that finds the greatest peaks (maxima) in a time series \[[@pone.0237854.ref065]\]. A solid vertical line was superimposed on the image at this point perpendicular to the X-axis to show the location of the R-waves on the ECG, and delineate individual heartbeats. Detecting the R wave in the vast majority of ECGs is straightforward, as it consistently has the greatest amplitude. This is in contrast to the other waveforms which vary considerably across ECGs. As high quality ECG signals were used in the study, this method proved accurate and efficient. Where signal data is lower quality, it may be necessary to use alternative detection methods that can reliably distinguish R-peaks from high amplitude noises (see e.g. \[[@pone.0237854.ref066]--[@pone.0237854.ref069]\]).

### Applying the pseudo-colouring {#sec008}

The traditional way to measure the QT-interval clinically is to count the small squares (each representing 40ms) on the standard ECG background grid, from the beginning of the Q-wave to the end of the T-wave. For the purposes of applying the pseudo-colouring, we added sequential time in ms as a third dimension to each heartbeat, from the R-peak minus 20ms (the estimated start of the Q-wave), to the clinically significant point of maximum risk for TdP---the method for estimating this is provided in the next section. We then applied pseudo-colouring to the area under the curve of the ECG signal by mapping every 40ms of this sequential time to a colour code or hue, with the intensity of the hue changing every millisecond. We used a spectrum-approximation sequence as it is effective for supporting people in reading continuous values \[[@pone.0237854.ref070]\]; it ranges from cool colours (purple to blue to green), which were used to indicate normal QT-interval levels, to warm colours (yellow to orange to red), used to show prolonged QT-interval levels.

### Adjusting pseudo-colouring according to heart rate using the QT nomogram {#sec009}

To apply the pseudo-colouring accurately for different heart rates, it was necessary to identify the value of QT-prolongation that determines being 'at risk' for TdP. In the previous study \[[@pone.0237854.ref051]\], where all ECGs had a 60 bpm heart rate, we used the half R-R interval rule to identify at risk QT-prolongation. This states that the QT-interval is prolonged if it is equal to or longer than the half R-R interval (midpoint between two consecutive R-peaks) \[[@pone.0237854.ref052], [@pone.0237854.ref071]\]. This rule is accurate with a heart rate of 60 bpm, but lacks sensitivity in detecting at risk QT-prolongation with both lower and higher heart rates \[[@pone.0237854.ref052], [@pone.0237854.ref072]\]. In clinical practice it is common to apply a QT correction formula (QTc), and then use a 'cut off' value to identify at risk QT-prolongation. Examples of such QTc formulae include Bazett's, Fredericia's, Framingham's and Hodge's \[[@pone.0237854.ref052]\]. However, recent research has shown that these correction formulae are inaccurate in identifying patients at risk of drug-induced TdP, particularly for fast and slow heart rates \[[@pone.0237854.ref052], [@pone.0237854.ref073]\].

An alternative approach, known as the 'QT nomogram', is a risk assessment method designed specifically for identifying patients at risk of drug-induced TdP according to heart rate \[[@pone.0237854.ref074], [@pone.0237854.ref075]\]. It was developed after screening 129 ECG cases that reported drug-induced TdP and comparing these with control cases (i.e. when no TdP was reported). The actual QT-interval value (not the QTc) and the heart rate for each case were plotted as coordinates on a graph; this produced a line showing the upper bound of the QT-interval value at risk for TdP as a function of heart rate. If the QT/HR value falls on or above this risk line, the patient is at risk of TdP; below the line the patient is not considered at risk of TdP \[[@pone.0237854.ref074]\]. The nomogram plot can be seen in [Fig 2](#pone.0237854.g002){ref-type="fig"}. Further evaluation of the QT nomogram showed that it had higher sensitivity and specificity than widely accepted QTc formulas \[[@pone.0237854.ref076]\] and the half R-R interval rule \[[@pone.0237854.ref072]\]. We therefore used it as the foundation for modifying the pseudo-colour as a function of heart rate.

![The QT-nomogram for identifying QT-prolongation at risk of TdP over heart rate.\
If the QT/HR value falls on or above the risk line, the patient is at risk of TdP; below the line the patient is not considered at risk of TdP \[[@pone.0237854.ref074]\].](pone.0237854.g002){#pone.0237854.g002}

For each ECG, the heart rate (HR) was calculated and then the corresponding QT value for the 'at risk' threshold was acquired from the QT nomogram and plotted on the ECG as a dashed vertical line. To apply the pseudo-colouring, we used nine indices, where each was mapped to a colour code and represented by a small square on the standard ECG background grid. A time value on the nomogram threshold line was mapped to dark orange, and values 40ms and 80ms above the nomogram line were mapped to red and dark red respectively, showing a higher risk for TdP. Time values below the nomogram line were mapped to progressively cooler colours, such that a time value below the line by five small squares (200ms), was mapped to blue. [Fig 3](#pone.0237854.g003){ref-type="fig"} illustrates how the pseudo-colouring technique was applied according to the standard ECG background grid. The mappings between colours and time values according to the nomogram is shown in [Table 1](#pone.0237854.t001){ref-type="table"}. Note that this approach does not provide a numerical value for the QT-interval, but rather colours the area under the curve of the signal over a specific time interval (40ms × 9 indices = 360ms) according to the nomogram. The T-wave area lies within this time interval: if the T-wave is in a cool colour location, then the QT-interval is in the normal range; if it is in a warm colour location, the interval is prolonged.

![Mapping the pseudo-colouring to the ECG, according to the QT-nomogram.\
A small square on the standard ECG background grid is equal to 40ms.](pone.0237854.g003){#pone.0237854.g003}

10.1371/journal.pone.0237854.t001

###### The nine indices on the pseudo-colouring scale with their corresponding time values and colour codes.

![](pone.0237854.t001){#pone.0237854.t001g}

  Index   The corresponding time value (ms)          Colour code
  ------- ------------------------------------------ -------------
  1       QT-value of the nomogram line---(40 × 6)   Purple
  2       QT-value of the nomogram line---(40 × 5)   Blue
  3       QT-value of the nomogram line---(40 × 4)   Green
  4       QT-value of the nomogram line---(40 × 3)   Lime
  5       QT-value of the nomogram line---(40 × 2)   Yellow
  6       QT-value of the nomogram line---(40 × 1)   Orange
  7       QT-value of the nomogram line              Dark orange
  8       QT-value of the nomogram line + (40 × 1)   Red
  9       QT-value of the nomogram line + (40 × 2)   Dark red

### Coordinate system {#sec010}

Our previous work indicates that people may be able to detect QT-prolongation more accurately on a Polar coordinate system \[[@pone.0237854.ref051]\]. To see whether this held when ECGs with varying heart rates are presented in isolation, we compared two coordinate systems (Cartesian and Polar) with and without pseudo-colouring. We used the R programming language \[[@pone.0237854.ref077]\] using RStudio software version 1.1.447 to create the visualisations. [Fig 4](#pone.0237854.g004){ref-type="fig"} shows examples of ECGs with pseudo-colouring that have different heart rates, but similar QT-interval risk levels for TdP, on Cartesian coordinates. [Fig 5](#pone.0237854.g005){ref-type="fig"} shows the same ECGs on Polar coordinates.

![Pseudo-coloured ECGs that have different heart rates, but similar QT-interval risk levels, on Cartesian coordinates.\
(A) QT-intervals are below the nomogram line by 80ms for both ECGs (no risk of TdP). The top stimulus has a low heart rate (HR = 57, QT = 401) and the bottom has a high heart rate (HR = 95, QT = 339). (B) QT-intervals are on the nomogram line in both ECGs (risk of TdP). The top stimulus has a low heart rate (HR = 46, QT = 487) and the bottom has a high heart rate (HR = 94, QT = 410).](pone.0237854.g004){#pone.0237854.g004}

![Pseudo-coloured ECGs that have different heart rates, but similar QT-interval risk levels, on Polar coordinates.\
(A) QT-intervals are below the nomogram line by 80ms for both ECGs (no risk of TdP). The left stimulus has a low heart rate (HR = 57, QT = 401) and the right has a high heart rate (HR = 95, QT = 339). (B) QT-intervals are on the nomogram line in both ECGs (risk of TdP). The left stimulus has a low heart rate (HR = 46, QT = 487) and the right has a high heart rate (HR = 94, QT = 410).](pone.0237854.g005){#pone.0237854.g005}

Experimental design {#sec011}
-------------------

We used a multi-reader, multi-case (MRMC) receiver operating characteristic (ROC) study design within a psychophysical paradigm. The MRMC ROC design is an evaluation method commonly used to assess diagnostic performance in medical imaging studies, where multiple human observers (readers) interpret multiple patient images (cases) \[[@pone.0237854.ref078]\]. The area under the ROC curve, a plot of sensitivity versus 1-specificity, is used to measure diagnostic accuracy. The MRMC design helps to increase the generalisability of study results and enhance statistical power, particularly when evaluating different computer-assisted detection (CAD) systems \[[@pone.0237854.ref078]\]. Psychophysical experiments use detection and discrimination tasks to investigate the relationship between the intensity of a physical stimulus and human perception and sensation, by systematically varying the properties of the stimulus along one or more physical dimensions \[[@pone.0237854.ref079]\]. Here the paradigm was used to systematically evaluate the impact of the visualisation technique on people's sensitivity to increases in the QT-interval. We also used eye-tracking, a non-invasive sensor technology that measures human eye movements, to help us interpret the visual behaviour underpinning the results on a *post hoc* basis \[[@pone.0237854.ref080]\].

The study used a counterbalanced repeated measures design with two independent variables, each with two levels: Colour-coding (no colouring and pseudo-colouring).Coordinate system (Cartesian and Polar).

The within-subjects factorial design yielded a total of 4 (2×2) experimental conditions for each participant: Cartesian no-colouring; Cartesian pseudo-colouring; Polar no-colouring; Polar pseudo-colouring. We counterbalanced the order of visualisation presentation using a balanced Latin square to minimize practice effects. The dependent variables were accuracy (broken down into sensitivity and specificity), reaction time in ms, satisfaction with the visualisation on a five point Likert-type scale from low (1) to high (5), mean fixation duration, total fixation duration and spatial fixation distribution.

Stimulus design {#sec012}
---------------

The heart rates of the ECGs acquired from the clinical trial ranged from 40 to 96 bpm, and the QT-interval values ranged from 300 to 579ms. As such, bradycardia (HR \<60 bpm) was included in the range of heart rates, but not tachycardia (HR \>100 bpm).

We followed psychophysical experimental design principles to systematically select the study's stimuli. We considered QT interval value, relative to the nomogram line, to be the physical dimension along which the stimulus was varied, in units of 40ms. Six levels of the QT-interval were identified: three levels below the nomogram line (no/low risk to borderline), one level on the nomogram line (moderate risk), and two levels above the nomogram line (high risk). The six QT levels were represented by indices 4 to 9 on the pseudo-colouring scale respectively (see [Table 1](#pone.0237854.t001){ref-type="table"}). [Fig 6](#pone.0237854.g006){ref-type="fig"} shows examples of ECGs with the first QT-level (normal), and the sixth QT-level (severely prolonged), while Figs [4](#pone.0237854.g004){ref-type="fig"} and [5](#pone.0237854.g005){ref-type="fig"} show examples of ECGs with the second QT-level (normal) and the fourth QT-level (prolonged). [Table 2](#pone.0237854.t002){ref-type="table"} shows the corresponding estimated QT-interval prolongation for the six levels.

![Pseudo-coloured ECGs that have similar heart rates, but different QT-interval risk levels, on Cartesian coordinates.\
(A) Normal QT-interval (HR = 55, QT = 361). (B) Severely prolonged QT-interval (HR = 52, QT = 579).](pone.0237854.g006){#pone.0237854.g006}

10.1371/journal.pone.0237854.t002

###### The six QT-levels with their corresponding QT-value relative to the nomogram and an estimated range.

![](pone.0237854.t002){#pone.0237854.t002g}

  QT-level   QT-value relative to the QT-nomogram line   Estimated range
  ---------- ------------------------------------------- --------------------
  1          QT-value of the nomogram line---(40 × 3)    Normal
  2          QT-value of the nomogram line---(40 × 2)    Normal
  3          QT-value of the nomogram line---(40 × 1)    Borderline
  4          QT-value of the nomogram line               Prolonged
  5          QT-value of the nomogram line + (40 × 1)    Very prolonged
  6          QT-value of the nomogram line + (40 × 2)    Severely prolonged

ECG case selection {#sec013}
------------------

Forty ECG cases were selected from multiple patients (*n* = 17) to match the six QT-levels. Twenty ECGs were below the nomogram line (i.e. no risk of TdP) and 20 ECGs were on or above the nomogram line (i.e. at risk of TdP). Six ECG cases were on a placebo, and had values corresponding to the first QT-level, across heart rates ranging from 48 to 90 bpm. The other 34 ECG cases (18 on Dofetilide, a known QT-prolonging drug with a pure hERG potassium channel blocker, and 16 on Quinidine, a multichannel blocker with a strong hERG block, and lesser calcium and late sodium blocks), represented the second to sixth QT-levels across heart rates from 42 to 96 bpm. [Table 3](#pone.0237854.t003){ref-type="table"} shows the metadata of each ECG case in terms of QT value, heart rate, drug type, patient ID, the corresponding QT-level relative to the nomogram line and whether the case was at risk for TdP or not based on the nomogram plot.

10.1371/journal.pone.0237854.t003

###### Characteristics of the 40 selected ECG cases used in the study.

![](pone.0237854.t003){#pone.0237854.t003g}

  ECG ID   QT value   Heart rate   Drug type    Patient ID   QT-level   Risk for TdP on the nomogram
  -------- ---------- ------------ ------------ ------------ ---------- ------------------------------
  1        370        48           Placebo      11           1          Not at risk
  2        361        55           Placebo      13           1          Not at risk
  3        350        68           Placebo      16           1          Not at risk
  4        343        72           Placebo      16           1          Not at risk
  5        329        83           Placebo      18           1          Not at risk
  6        335        90           Placebo      4            1          Not at risk
  7        401        57           Dofetilide   12           2          Not at risk
  8        389        75           Dofetilide   18           2          Not at risk
  9        339        95           Dofetilide   20           2          Not at risk
  10       419        47           Quinidine    8            2          Not at risk
  11       396        68           Quinidine    16           2          Not at risk
  12       355        82           Quinidine    18           2          Not at risk
  13       445        46           Dofetilide   2            3          Not at risk
  14       441        67           Dofetilide   7            3          Not at risk
  15       431        75           Dofetilide   8            3          Not at risk
  16       417        80           Dofetilide   11           3          Not at risk
  17       371        94           Dofetilide   17           3          Not at risk
  18       444        58           Quinidine    4            3          Not at risk
  19       424        76           Quinidine    10           3          Not at risk
  20       363        95           Quinidine    22           3          Not at risk
  21       487        46           Dofetilide   4            4          At risk
  22       468        72           Dofetilide   8            4          At risk
  23       451        79           Dofetilide   9            4          At risk
  24       445        81           Dofetilide   10           4          At risk
  25       486        54           Quinidine    7            4          At risk
  26       485        64           Quinidine    7            4          At risk
  27       419        91           Quinidine    15           4          At risk
  28       410        94           Quinidine    19           4          At risk
  29       523        42           Dofetilide   4            5          At risk
  30       494        71           Dofetilide   9            5          At risk
  31       470        85           Dofetilide   18           5          At risk
  32       565        49           Dofetilide   4            6          At risk
  33       579        52           Dofetilide   18           6          At risk
  34       547        64           Dofetilide   21           6          At risk
  35       518        54           Quinidine    4            5          At risk
  36       509        68           Quinidine    7            5          At risk
  37       482        80           Quinidine    9            5          At risk
  38       417        96           Quinidine    21           5          At risk
  39       518        77           Quinidine    21           6          At risk
  40       507        79           Quinidine    21           6          At risk

The metadata were acquired from the clinical trial study \[[@pone.0237854.ref063]\], published by PhysioNet database \[[@pone.0237854.ref064]\].

Participants {#sec014}
------------

A total of forty three participants, with no experience in ECG interpretation, were recruited from a university campus (30 students and 13 staff). Eligibility for the study was determined by asking participants to rate their knowledge of ECG interpretation, and only people who identified as having no knowledge at all were included in the study. There were 18 male and 25 female participants between 20 and 56 years old (Mean = 31, *SD* = 8). [Table 4](#pone.0237854.t004){ref-type="table"} shows the participants' demographic data. Participants' sight was normal or corrected-to-normal and they reported no motor or neurological disorders. The research was approved by the University Research Ethics Committee). All participants provided written informed consent.

10.1371/journal.pone.0237854.t004

###### Participant demographics.

![](pone.0237854.t004){#pone.0237854.t004g}

  Category                     Count   Percentage %
  ---------------------------- ------- --------------
  Age                                  
  20-30                        25      58%
  31-40                        13      30%
  41-50                        3       7%
  50+                          2       5%
  Sex                                  
  Male                         18      42%
  Female                       25      58%
  Occupation                           
  University Staff             13      30%
  Student                      30      70%
  Background                           
  Computer science             27      63%
  Chemical engineering         1       2%
  Psychology                   3       7%
  Biochemistry                 4       9%
  Interior design              1       2%
  Mathematics                  1       2%
  Art, history and sociology   1       2%
  Biomedical sciences          4       9%
  Business                     1       2%

Apparatus {#sec015}
---------

Stimuli were displayed on a 23.8 inch (diagonal) wide-screen Spectrum eye-tracking monitor, with a resolution of 1920 × 1080 pixels. Eye gaze was recorded using the Tobii Pro Spectrum eye-tracker and Tobii Pro Lab 1.95 software with a sampling rate of 600Hz. Key press events were recorded during the experiment to measure reaction times. Each Cartesian coordinate ECG stimulus measured 32.31cm × 6.14cm, and each Polar coordinate stimulus was 15.61cm × 12.93cm.

Task and procedure {#sec016}
------------------

Participants completed a 15 minute training session prior to starting the experiment, where they were introduced to the ECG trace, and taught how to identify the QT-interval using the tangent method to identify the end of the T-wave (see [Fig 1](#pone.0237854.g001){ref-type="fig"} and \[[@pone.0237854.ref081]\]). Participants were instructed to use the tangent method visually on the screen (i.e. without any additional equipment) to roughly identify the end of the T-wave; the training session did not involve any medical terms or high-level training techniques typically associated with clinical ECG interpretation and focused solely on identification of the QT interval. Participants were then introduced to the four visualisation techniques, and shown how to use the pseudo-colouring scale and the risk threshold (represented by a dashed line) to assess the QT-interval. Participants were told that a QT-interval is considered prolonged if the T-wave ends on or exceeds the risk threshold dashed line, and when the pseudo-colouring within the QT-interval, and particularly in the Tpeak--Tend interval, contains warm colours (yellow/orange/red), with a greater visibility of warm colours indicating a higher level of QT-prolongation. Finally, participants completed an assessment task, in which they were asked to highlight the start and end points of the QT-intervals on two different ECGs and assess whether it is normal or abnormal using the visualisation techniques, to ensure that they understood how to perform the task. Participants were tested individually. They completed four tests, one for each visualisation technique, in which they read all ECG cases for one test before moving to the next. Participants read the same ECG cases using each visualisation technique. ECGs were presented at random within a test. Each test began with a five-point calibration of the eye-tracking apparatus. ECGs were presented one at a time, and participants completed two tasks: the first task used a psychophysical one alternative forced-choice paradigm (also known as a yes-no detection task), in which participants indicated verbally, as quickly as possible, whether they perceived the QT-interval as ('normal' or 'abnormal'), whilst pressing the space-bar on the keyboard to collect reaction time; the second task was to rate their confidence in their response using a 6-point scale of 'very likely normal' (1), 'probably normal' (2), 'possibly normal' (3), 'possibly abnormal' (4), 'probably abnormal' (5), and 'very likely abnormal' (6). There was no time limit imposed, but participants were encouraged to do the tasks as quickly as possible. The binary responses and the confidence scores were recorded on a spreadsheet during the experiment by the researcher. At the end of the experiment, participants were asked to provide their satisfaction with the visualisations by rating how much each helped them to assess the QT-interval using a five point Likert-type scale ranging from 'not very much' (1) to 'a lot' (5).

Statistical analysis methods {#sec017}
----------------------------

Response accuracy was measured by calculating the average area under the receiver operating characteristic (ROC) curves (AUC) with 95% confidence intervals (CIs). QT-levels 1-3 inclusive were classified as negative (normal), and levels 4-6 as positive (prolonged). We used the Dorfman-Berbaum-Metz multi-reader multi-case (DBM MRMC) software from the University of Iowa \[[@pone.0237854.ref082]\], to calculate and compare the AUCs of the four visualisation techniques, based on the methods of Dorfman, Berbaum and Metz \[[@pone.0237854.ref083]\] and Obuchowski and Rockette \[[@pone.0237854.ref084]\] and later unified and improved by Hillis and colleagues \[[@pone.0237854.ref078], [@pone.0237854.ref085], [@pone.0237854.ref086]\]. The DBM MRMC method uses jackknifing and analysis of variance (ANOVA) methods and we considered both readers and cases as random variables; this allows the results to be generalised to the population of readers and cases. The ROC curve was fitted using the trapezoidal area and Wilcoxon method. The statistical power of ROC MRMC was greater than 90%, and the sample size estimation was performed using \[[@pone.0237854.ref087]\].

All statistical tests were performed at a 5% significance level (*α* = 0.05); two-sided 95% confidence intervals (CIs) were used to quantify uncertainty. Within-participant comparisons of sensitivity and specificity were performed using McNemar's chi-squared test. We measured perceptual sensitivity to QT-levels using the psychometric function and just noticeable difference (JND) threshold, along with the signal detection analysis method R packages \[[@pone.0237854.ref088], [@pone.0237854.ref089]\]. Differences in reaction time and satisfaction scores were determined via a Friedman test and *post hoc* pairwise comparisons performed with a Wilcoxon signed-rank test utilising a Bonferroni correction (*α* = 0.008). Visual behaviour was analysed using eye tracking metrics including mean fixation duration, total fixation duration and fixation distribution using the nearest neighbour index (NNI) method, as implemented by Davies *et al*. \[[@pone.0237854.ref090]\].

Results {#sec018}
=======

All anonymised data and related metadata underpinning the findings reported in this article can be found in \[[@pone.0237854.ref062]\].

Accuracy {#sec019}
--------

### Area under the ROC curve {#sec020}

Pseudo-colouring significantly increased the average area under the ROC curve (AUC) for both coordinate systems (Tables [5](#pone.0237854.t005){ref-type="table"} and [6](#pone.0237854.t006){ref-type="table"}). When Cartesian coordinates were used, the average AUC increased from 0.895 (standard error (SE) = 0.024) to 0.935 (SE = 0.020), while the increase was from 0.878 (SE = 0.029) to 0.934 (SE = 0.023) for Polar coordinates ([Table 5](#pone.0237854.t005){ref-type="table"}). The average increase in AUC as a result of pseudo-colouring was therefore 0.04 for Cartesian and 0.056 for Polar coordinates, a statistically significant increase in both cases (*p* = 0.014, *p* \< 0.001 for Cartesian and Polar coordinates respectively, see [Table 6](#pone.0237854.t006){ref-type="table"}). There was no significant difference in average AUC as a function of coordinate system when pseudo-colouring was used (*p* = 0.978, see [Table 6](#pone.0237854.t006){ref-type="table"}). Although the average AUC was higher for Cartesian coordinates than for Polar coordinates when no-colouring was used, the difference was not statistically significant (*p* = 0.273, see [Table 6](#pone.0237854.t006){ref-type="table"}).

10.1371/journal.pone.0237854.t005

###### The average area under the ROC curve across all participants and for each visualisation technique.

![](pone.0237854.t005){#pone.0237854.t005g}

  Visualisation technique      Average AUC   SE      %95 CI
  ---------------------------- ------------- ------- ----------------
  Cartesian no-colouring       0.895         0.024   0.848 to 0.943
  Cartesian pseudo-colouring   0.935         0.020   0.895 to 0.974
  Polar no-colouring           0.878         0.029   0.821 to 0.935
  Polar pseudo-colouring       0.934         0.023   0.888 to 0.980

SE = Standard error. CI = %95 Confidence intervals.

10.1371/journal.pone.0237854.t006

###### Pairwise comparisons of the area under the ROC curve for the four visualisation techniques.

![](pone.0237854.t006){#pone.0237854.t006g}

  Pairwise comparisons                                 AUC Difference   SE      P-value       95% CI
  ---------------------------------------------------- ---------------- ------- ------------- ------------------
  Cartesian no-colouring, Cartesian pseudo-colouring   -0.039           0.015   **0.014**     -0.070 to -0.007
  Cartesian no-colouring, Polar no-colouring           0.017            0.015   0.273         -0.013 to 0.048
  Cartesian no-colouring, Polar pseudo-colouring       -0.038           0.015   **0.015**     -0.070 to -0.007
  Cartesian pseudo-colouring, Polar no-colouring       0.056            0.015   **\<0.001**   0.025 to 0.087
  Cartesian pseudo-colouring, Polar pseudo-colouring   0.000            0.015   0.978         -0.030 to 0.031
  Polar no-colouring, Polar pseudo-colouring           -0.056           0.015   **\<0.001**   -0.087 to -0.024

Significant p-values are in bold. SE = Standard error. CI = %95 Confidence intervals.

### Specificity {#sec021}

Specificity was calculated as the proportion of true negative (i.e. 'normal') responses for QT-levels 1 to 3. The mean specificity across all participants was high and similar for both coordinate systems regardless of pseudo-colouring was used ([Table 7](#pone.0237854.t007){ref-type="table"}). Although pseudo-colouring increased the mean specificity for Polar coordinates from 0.88 (SE = 0.002) to 0.90 (SE = 0.002), the increase was not statistically significant (*p* = 0.460). The highest mean specificity was 0.94 (SE = 0.002) for Cartesian coordinates when pseudo-colouring was not used, which was significantly higher than when pseudo-colouring was used with this coordinate system (*p* \< 0.001). There was no difference in the mean specificity between the two coordinate systems when pseudo-colouring was used (*p* = 1.000).

10.1371/journal.pone.0237854.t007

###### Comparisons of mean specificity between the visualisation techniques.

![](pone.0237854.t007){#pone.0237854.t007g}

  Coordinate        Pseudo-colouring   No-colouring       Difference     P-value
  ----------------- ------------------ ------------------ -------------- -------------
  Cartesian         0.90±0.002,        0.94±0.002,        −0.04±0.002,   **\<0.001**
  0.870 to 0.929    0.913 to 0.966     -0.069 to -0.014                  
  Polar             0.90±0.002,        0.88±0.002,        0.02±0.002,    0.460
  0.874 to 0.925    0.849 to 0.910     -0.024 to 0.044                   
  Difference        0.00±0.002,        0.06±0.002,                       
  -0.030 to 0.030   0.0260 to 0.073                                      
  P-value           1.000              **\<0.001**                       

The table shows the mean ± standard error, and 95% two-sided confidence intervals. Significant p-values are in bold and were calculated using a McNemar's chi-squared test.

### Sensitivity {#sec022}

Sensitivity was measured using the ROC method as the proportion of true positive (i.e. 'abnormal') responses for QT-levels 4 to 6. The mean sensitivity increased with pseudo-colouring from 0.63 (SE = 0.004) to 0.83 (SE = 0.003) with Cartesian coordinates, and from 0.72 (SE = 0.004) to 0.82 (SE = 0.003) with Polar coordinates ([Table 8](#pone.0237854.t008){ref-type="table"}). The increase in sensitivity of 0.2 (SE = 0.004) with Cartesian and 0.1 (SE = 0.003) with Polar coordinates was statistically significant (*p* \< 0.001). Sensitivity was higher when Cartesian coordinates were used than when Polar coordinates were used by 0.01, a statistically significant difference (*p* = 0.001). When pseudo-colouring was not used, the mean sensitivity was 0.09 (SE = 0.003) higher with Polar coordinates than with Cartesian coordinates, a difference that was statistically significant (*p* \< 0.001).

10.1371/journal.pone.0237854.t008

###### Comparisons of mean sensitivity between the visualisation techniques.

![](pone.0237854.t008){#pone.0237854.t008g}

  Coordinate        Pseudo-colouring   No-colouring     Difference   P-value
  ----------------- ------------------ ---------------- ------------ -------------
  Cartesian         0.83±0.003,        0.63±0.004,      0.2±0.004,   **\<0.001**
  0.773 to 0.877    0.570 to 0.689     0.138 to 0.261                
  Polar             0.82±0.003,        0.72±0.004,      0.1±0.003,   **\<0.001**
  0.779 to 0.860    0.665 to 0.774     0.050 to 0.149                
  Difference        0.01±0.003,        −0.09±0.003,                  
  -0.030 to 0.050   -0.140 to -0.039                                 
  P-value           **0.001**          **\<0.001**                   

The table shows the mean ± standard error, and 95% two-sided confidence intervals. Significant p-values are in bold and were calculated using a McNemar's chi-squared test.

We also measured perceptual sensitivity across QT-levels using the following psychophysical detection methods:

*(1) Psychometric function and just noticeable difference (JND)*. We used a psychometric function, an inferential model used in psychophysical detection and discrimination tasks, to model the relationship between QT-level increases and participants' sensitivity across the four visualisation techniques. The psychometric function was plotted as the proportion of responses that indicated a QT-prolongation as a function of the QT-level. The results show that pseudo-colour significantly improved the perception of QT-interval increases regardless of heart rate with both coordinate systems (see [Fig 7A](#pone.0237854.g007){ref-type="fig"}). We estimated the just noticeable difference (JND) threshold, which is defined in psychophysics as the smallest change required in a dimension of a stimulus in order for a difference to be perceived \[[@pone.0237854.ref079]\]. In this study, we defined it as the minimum increase in the QT-interval with respect to the nomogram line required for it to be detectable. We estimated the 75% JND threshold as the value of the QT-interval increase from the nomogram line at which the proportion of responses indicating QT-prolongation is equal to 0.75. The JND thresholds, determined by fitting the psychometric function using a logistic function with maximum likelihood estimation (MLE) ([Fig 7B](#pone.0237854.g007){ref-type="fig"}), were 51.2, 6.9, 28.8 and 7.3 milliseconds for *Cartesian no-colouring*, *Cartesian pseudo-colouring*, *Polar no-colouring* and *Polar pseudo-colouring* respectively. Pseudo-colour thus reduces the JND in both coordinate systems, showing that 75% of people are able to perceive a QT-interval as prolonged when the QT-value above the nomogram line increases by approximately 6.9 and 7.3ms with Cartesian and Polar coordinates respectively. When pseudo-colouring was not used, the JND was 51.2 and 28.8ms for Cartesian and Polar coordinates respectively, showing that sensitivity was higher for Polar than Cartesian coordinates.

![Psychophysical detection measures of sensitivity.\
(A) The fitted psychometric function plot shows the proportion of responses indicating QT-prolongation as a function of the QT-interval difference from the nomogram line, which corresponds to the six QT-levels. The QT value of the nomogram line (i.e. the fourth QT-level) is equal to 0 on the X-axis. Cartesian no-colouring is represented by a red line, Cartesian pseudo-colouring by a green line, Polar no-colouring by a turquoise line and Polar pseudo-colouring by a purple line. (B) The just noticeable difference (JND) thresholds plot. The error bars represent bootstrap confidence intervals.](pone.0237854.g007){#pone.0237854.g007}

*(2) Signal detection analysis*. The psychometric function and JND threshold quantify sensitivity in terms of a binary response (here, 'normal' or 'abnormal'). In psychophysics, signal detection theory recognises that there is uncertainty in the task, such that the decision may be affected by noise either externally, for example where a stimulus changes between presentations, or internally, as people may be biased towards saying 'normal' or 'abnormal' more frequently \[[@pone.0237854.ref079]\]. We attempted to minimise the effect of decision bias by increasing sample size, counterbalancing experimental conditions, and including confidence scores, but some uncertainty is likely to remain. Signal detection theory measures the sensitivity, while taking response bias into account, using a sensitivity index *d*′ \[[@pone.0237854.ref079]\]. This was calculated for each participant and then averaged across all participants. [Table 9](#pone.0237854.t009){ref-type="table"} shows the mean sensitivity index (*d*′) with the standard deviation and standard error for each visualisation technique. The results show that pseudo-colouring increased the mean sensitivity with both coordinate systems independent of decision bias.

10.1371/journal.pone.0237854.t009

###### The mean sensitivity index for each visualisation technique.
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  Visualisation technique      Sensitivity index (*d*′)   SD     SE
  ---------------------------- -------------------------- ------ ------
  Cartesian no-colouring       1.87                       0.55   0.01
  Cartesian pseudo-colouring   2.22                       0.49   0.01
  Polar no-colouring           1.82                       0.57   0.01
  Polar pseudo-colouring       2.15                       0.44   0.01

SD = Standard deviation. SE = Standard error.

Reaction time {#sec023}
-------------

We measured reaction time as the period from the appearance of the stimulus on the screen to the key press event when people made their binary decision. The mean reaction times across all stimuli were 7.9 and 8.6 seconds for Cartesian coordinates with and without pseudo-colouring respectively, and 8.1 and 8.9 seconds for Polar coordinates with and without pseudo-colouring respectively. A Friedman test was conducted for each QT-level stimulus and overall for each condition. People were significantly faster when pseudo-colouring was used for each QT-level and over all ECG stimuli cumulatively (*p* ≤ 0.001)([Table 10](#pone.0237854.t010){ref-type="table"}, [Fig 8](#pone.0237854.g008){ref-type="fig"}). A *post hoc* pairwise comparison using a Wilcoxon signed-rank test with Bonferroni correction (*α* = 0.008) showed that although participants responded faster when pseudo-colouring was used with Cartesian coordinates than with Polar coordinates, the difference was not significant (*p* = 0.808).

![Mean reaction time in seconds for each QT-level and all stimuli combined.\
Error bars represent 95% confidence intervals.](pone.0237854.g008){#pone.0237854.g008}

10.1371/journal.pone.0237854.t010

###### Results of the Friedman test comparing reaction times across the four visualisation techniques.
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  QT-level   Estimated Range      Risk for TdP   *χ*^2^(3)   p-value
  ---------- -------------------- -------------- ----------- -------------
  1          Normal               No risk        35.251      **\<0.001**
  2          Normal               No risk        26.307      **\<0.001**
  3          Borderline           No risk        16.349      **0.001**
  4          Prolonged            At risk        18.216      **\<0.001**
  5          Very Prolonged       At risk        32.223      **\<0.001**
  6          Severely prolonged   At risk        48.008      **\<0.001**
  Overall    All ECG stimuli                     141.737     **\<0.001**

Satisfaction {#sec024}
------------

A Friedman test showed there was a statistically significant difference in participants' satisfaction as a function of visualisation technique (*χ*^2^(3) = 50.954, *p* \< 0.001). A *post hoc* pairwise comparison using a Wilcoxon signed-rank test with Bonferroni correction (*α* = 0.008) showed that people preferred pseudo-colouring to no-colouring (*p* \< 0.008); and Cartesian coordinates to Polar coordinates whether pseudo-colouring was used (*Z* = −3.340^*c*^, *p* = 0.001), or not (*Z* = −3.029^*c*^, *p* = 0.002). Although people were more sensitive to QT-prolongation when the ECG was presented on Polar coordinates with pseudo-colouring, people preferred Cartesian coordinates without pseudo-colouring to Polar coordinates with pseudo-colouring (*Z* = −2.142^*b*^, *p* = 0.032).

Eye movement analysis {#sec025}
---------------------

An area of interest (AOI) was created on the whole ECG for each stimulus. As such, 160 AOIs were created (40 ECGs × 4 visualisation techniques).

### Mean fixation duration {#sec026}

The mean fixation duration metric, which is an indicator of cognitive load \[[@pone.0237854.ref091], [@pone.0237854.ref092]\], was calculated across all participants for each ECG stimulus and then averaged over each QT-level. Mean fixation duration increased as the QT-level increased when pseudo-colouring was used ([Fig 9A](#pone.0237854.g009){ref-type="fig"}). When considered alongside the psychometric function ([Fig 7A](#pone.0237854.g007){ref-type="fig"}), this indicates that pseudo-colour helped people to focus visual attention. When pseudo-colouring was not used, mean fixation duration continued to increase at higher QT-levels for Cartesian coordinates, but this effect was not seen with Polar coordinates, indicating a difference in how people interpreted the ECG as a function of coordinate system.

![Eye movement analysis results.\
(A) Mean fixation duration in milliseconds on the ECG stimuli averaged for each QT-level. (B) Total fixation duration in milliseconds on the ECG stimuli averaged for each QT-level.](pone.0237854.g009){#pone.0237854.g009}

### Total fixation duration {#sec027}

The total fixation duration (also known as the dwell time) quantifies the amount of time spent fixating on the stimulus \[[@pone.0237854.ref091]\]. It was calculated across all participants for each stimulus and then averaged for each QT-level. The results show that total fixation duration was lower when pseudo-colouring was used for both coordinate systems ([Fig 9B](#pone.0237854.g009){ref-type="fig"}). People spent less cumulative time fixating on the ECG stimuli with pseudo-colouring, but individual fixations were more focused ([Fig 9A and 9B](#pone.0237854.g009){ref-type="fig"}). When pseudo-colouring was not used, there were more, shorter fixations, indicating a less-focused interpretation strategy.

### Fixation distribution {#sec028}

Figs [10](#pone.0237854.g010){ref-type="fig"} and [11](#pone.0237854.g011){ref-type="fig"} show heatmaps of fixations across an ECG stimulus with and without pseudo-colouring, for Cartesian and Polar coordinate systems respectively. We hypothesised that pseudo-colour helped to draw people's attention to the coloured T-wave area, and that fixations would therefore be more clustered when pseudo-colour was used. We used the Nearest Neighbour Index (NNI) to determine if the fixations were randomly spaced or clustered. The NNI provides a ratio of the distribution pattern of points in space from 0 (clustered) to 1 (dispersed) \[[@pone.0237854.ref090]\]. We calculated the average Nearest Neighbour Index (NNI) for each ECG stimulus across all participants and for all visualisation techniques. [Fig 12](#pone.0237854.g012){ref-type="fig"} shows a histogram of the distribution of the Nearest Neighbour Index (NNI), along with a box-plot for Cartesian and Polar coordinates, with and without pseudo-colouring. When Cartesian coordinates were used ([Fig 12A](#pone.0237854.g012){ref-type="fig"}), pseudo-colouring resulted in clustering in more stimuli than no-colouring. When Polar coordinates were used ([Fig 12B](#pone.0237854.g012){ref-type="fig"}), however, pseudo-colouring did not appear to affect the fixation distribution.

![A heatmap of fixation count shows the cumulative number of fixations across all participants on Cartesian coordinates.\
With pseudo-colouring, people made fewer, more clustered fixations on the coloured T-wave area compared with no-colouring on the same ECG.](pone.0237854.g010){#pone.0237854.g010}

![A heatmap of fixation duration shows the cumulative mean fixation duration across all participants on Polar coordinates.\
With pseudo-colouring, fixations were longer on the coloured T-wave area and the vertical dashed line that represents the QT risk threshold, while with no-colouring fixations were longer on the vertical dashed line only.](pone.0237854.g011){#pone.0237854.g011}

![Nearest Neighbour Index (NNI) of fixations on ECGs with and without pseudo-colouring.\
(A) Cartesian coordinates. (B) Polar coordinates.](pone.0237854.g012){#pone.0237854.g012}

Discussion {#sec029}
==========

This study demonstrates that applying pseudo-colouring to an ECG relative to the QT nomogram significantly increases lay people's accuracy in visually assessing QT-intervals regardless of heart rate (Tables [5](#pone.0237854.t005){ref-type="table"} and [6](#pone.0237854.t006){ref-type="table"}). In particular, pseudo-colouring increased sensitivity to prolongation (true positive cases); whilst people were able to identify normal QT-intervals without colour, adding pseudo-colouring resulted in more accurate identification of at risk QT-prolongation cases, shown by both the ROC curve analysis and the psychophysical detection measures of sensitivity (Tables [8](#pone.0237854.t008){ref-type="table"} and [9](#pone.0237854.t009){ref-type="table"}; [Fig 7](#pone.0237854.g007){ref-type="fig"}). The psychometric function shows that pseudo-colour helped increase sensitivity to QT-interval increases even before a patient is at risk of TdP ([Fig 7A](#pone.0237854.g007){ref-type="fig"}), specifically in the borderline range (i.e. the third QT-level). This level could be critical from a clinical perspective as just a 40ms increase from this point could put someone at risk of TdP. Clinical research has shown that even small (∼10ms) QT-interval increases from the baseline should be regarded as a significant side effect of a QT-prolonging drug \[[@pone.0237854.ref093]--[@pone.0237854.ref095]\]. From the perspective of our study design, this meant that pseudo-colouring with Cartesian coordinates reduced specificity (true negative cases) at this level, as we considered it to be within the normal range. From a practical perspective, however, considering this level to be abnormal may serve a useful purpose.

Pseudo-colour significantly reduced reaction times and helped to focus visual attention on the areas of the ECG crucial for detecting QT-prolongation. Eye-tracking data showed that pseudo-colour consistently increased mean fixation duration as the QT-level increased ([Fig 9A](#pone.0237854.g009){ref-type="fig"}); when the ECG was presented on Cartesian coordinates, fixations were more clustered when pseudo-colouring was used ([Fig 12A](#pone.0237854.g012){ref-type="fig"}).

Obtaining a precise measurement of the QT-interval is known to be challenging. An important QT-interval increase may be just a few milliseconds, less than one small square on the ECG. This would be particularly difficult to detect at high heart rates, as the QT-interval length shrinks with the R-R interval length \[[@pone.0237854.ref040], [@pone.0237854.ref041]\]. Here, we demonstrate that pseudo-colour can support detection of QT prolongation regardless of heart rate without needing to measure the QT-interval (Figs [4](#pone.0237854.g004){ref-type="fig"} and [5](#pone.0237854.g005){ref-type="fig"}). [Fig 11](#pone.0237854.g011){ref-type="fig"} shows a heat map of absolute fixation duration across all participants on an ECG with a QT-interval 40ms above the nomogram line. When pseudo-colouring was not used, people's fixations appear to be more focused on measuring the gap between the end of the T-wave and the QT risk threshold dashed line. When pseudo-colouring is present on the same ECG, fixations appear more focused on the T-wave. Focusing attention in this area is particularly useful, as long QT syndrome (LQTS) is associated with prolonging ventricular repolarization \[[@pone.0237854.ref007], [@pone.0237854.ref008]\], which is represented by the T-wave on the ECG \[[@pone.0237854.ref001], [@pone.0237854.ref002]\]. Research examining the effects of QT-prolonging drugs is investigating precisely how the T-wave responds to them to provide further insights of drug ion channel interactions and TdP risk \[[@pone.0237854.ref042]\]. Pseudo-colour might ultimately help clinicians to determine which part of the T-wave---the initial half of the T-wave (J-T-peak) or the second half (T-peak T-end)---underpins QT-prolongation.

Limitations and future work {#sec030}
---------------------------

Whilst this work indicates the potential for pseudo-colouring to assist in the self-monitoring of QT-interval, the study took place in a controlled setting with a limited number of stimuli, and the transferability of the technique to practice remains an open question. Cartesian and Polar coordinates support the same level of accuracy, but people expressed a preference for pseudo-colour displayed on Cartesian coordinates. It may be, however, that the ECG trace would be better presented with Polar coordinates on smaller screens like smart watches, and future work should thus examine the effects of screen size and lighting setting on accuracy.

In this study, we only investigated the assessment of QT-interval, and it is not clear whether these visualisation techniques would generalise to interpretation of other ECG abnormalities, such as changes in ST-segment elevation. Research has shown that a large number of clinicians lack the skills to interpret QT-prolongation accurately \[[@pone.0237854.ref045], [@pone.0237854.ref046]\]; pseudo-colouring could also be used to help clinicians, especially within emergency departments, to visually assess and monitor patients' QT-intervals before or during the provision of a QT-prolonging medication. Future work should evaluate the visualisation techniques in clinical trials with more diverse clinical populations.

Conclusion {#sec031}
==========

Applying pseudo-colouring to ECGs according to the QT-nomogram supports lay people in detecting QT-prolongation visually, regardless of heart rate. The results indicate that self-monitoring ECGs for drug-induced LQTS is feasible, with the potential to prevent the development of life threatening complications.

We would like to thank the Digital Experimental Cancer Medicine Team (digitalECMT), Manchester, UK, for their feedback and support.
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A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled \'Manuscript\'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

We look forward to receiving your revised manuscript.

Kind regards,

Paweł Pławiak, D.Sc., Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1\. Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at <https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf> and <https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

2\. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

Additional Editor Comments (if provided):

Please correct the manuscript according to the comments of all reviewers. Please answer all the comments of the reviewers point by point.

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Partly

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: The authors proposed a pseudo-coloring ECG method to investigate drug-induced QT-prolongation sing eye-tracking study. In this study, the manual inspections of four types of ECG visualizations techniques are explored. The authors have performed an extensive level of statistical analysis to support their results. Overall, the article is well presented. However, the authors need to clarify the following reviewer\'s concerns for possible publication.

1\. Please improve the quality of the figures from Fig.4.

2\. The authors are encouraged to provide the details of the multi-reader multi-case Roc and eye-tracking method.

3\. Why authors not followed popular R-peak detection methods? Because the proposed scheme accuracy depends on the correct annotations of ECG events (P-QRS-T and QT interval).

4\. In the case of true negative cases, no-coloring schemes are giving better results, whereas, in the case of true positives, the scenario becomes opposite, colored schemes are outperforming. The authors are suggested to add this justification in the discussion section.

Reviewer \#2: Please change the title too lengthy and not clear. Make a crisp title.

It is just study or real contribution is there?

The motivation behind pseudo color any suh approaches in literature, needs a clear explanation.

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0237854.r002

Author response to Decision Letter 0

11 Jul 2020

Thanks to the reviewers for their comments and suggestions. Below we outline how we addressed each point raised by the reviewers.

Reviewer 1

1- Please improve the quality of the figures from Fig.4

We have improved the quality of all figures and double-checked them using the PACE tool provided by PLoS. We also uploaded all full size stimuli used in the study to our GitHub repository, which is referenced in the paper.

2- The authors are encouraged to provide the details of the multi-reader multi-case Roc and eye-tracking method.

We have now explained the methods in more detail in the 'experimental design' subsection.

3- Why authors not followed popular R-peak detection methods? Because the proposed scheme accuracy depends on the correct annotations of ECG events (P-QRS-T and QT interval).

The pseudo-colouring visualisation technique proposed in the paper does not require any prior annotations of ECG waveforms (P-QRS-T and QT interval); it only requires R-peak detection. As the ECG signals acquired from the clinical trial study were high quality, our R-peak detection method was accurate and efficient. We agree that with low quality ECG signals, using other R-peak detection methods that can reliably distinguish R-peaks from high amplitude noises is essential. We now added this clarification and suggestion under the 'Identifying individual heartbeats' subsection.

4- In the case of true negative cases, no-coloring schemes are giving better results, whereas, in the case of true positives, the scenario becomes opposite, colored schemes are outperforming. The authors are suggested to add this justification in the discussion section.

We now discussed these findings in more detail in the 'discussion' section, showing why the specificity (true negative cases) decreased with pseudo-colouring, which was mainly at the QT-level three/borderline to the nomogram.

Reviewer 2

1- Please change the title too lengthy and not clear. Make a crisp title.

We have now shortened the title

2- It is just study or real contribution is there?

To the best of our knowledge, no prior studies have examined how and to what extent using pseudo-colouring technique can support ECG interpretation. This statement is now added in the 'background and significance' section.

3- The motivation behind pseudo color any such approaches in literature, needs a clear explanation.

We have highlighted the part in the 'background and significance' section that explained the motivation behind the pseudo-colouring technique and provided examples of its applications in the literature.
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PONE-D-20-02458R1

Dear Dr. Alahmadi,

We're pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you'll receive an e-mail detailing the required amendments. When these have been addressed, you'll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <http://www.editorialmanager.com/pone/>, click the \'Update My Information\' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible \-- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

Kind regards,

Paweł Pławiak, D.Sc., Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: All comments have been addressed

Reviewer \#2: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: (No Response)

Reviewer \#2: Partly

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: (No Response)

Reviewer \#2: N/A

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: (No Response)

Reviewer \#2: No

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: (No Response)

Reviewer \#2: No

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: (No Response)

Reviewer \#2: please re check the presentation once. Some how not completely satisfied. But accepting it. It may be noted

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No
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Pseudo-colouring an ECG enables lay people to detect QT-interval prolongation regardless of heart rate

Dear Dr. Alahmadi:

I\'m pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they\'ll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

If we can help with anything else, please email us at <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Paweł Pławiak

Academic Editor

PLOS ONE
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